DNA Script

Innovations in DNA synthesis for biological development

B2B
Biology
Science
MedTech

See open opportunities

Company mission

To accelerate breakthroughs in life science and human health.

Employees

201-500

HQ Location

Le Kremlin-Bicêtre, France

OTTA INSIGHTS

14% employee growth in 12 months

Otta's take on DNA Script

Xav Kearney headshot

Xav Kearney

CTO of Otta

Outsourcing DNA synthesis can be a large problem for R&D labs, as unprecedented factors such as delivery delays or issues on arrival can lead to schedule alterations and material that is no longer suitable for use. DNA Script attempts to solve this issue by democratising DNA synthesis for laboratories everywhere.

DNA Script facilitates biological and scientific development through providing proprietary equipment to labs that facilitates in-house DNA synthesis. The equipment eliminates the need for a reliance on external sources, and can significantly speed up workflows and operational efficiencies.

An issue found with equipment is that the DNA synthesised may vary in quality across locations, a problem that the company is committed to addressing through investigations and evaluation. By increasing the ability of labs to carry out DNA synthesis, the possibilities of the tech are vast and have the potential for significant revolutionary scientific developments. 2022 funding has facilitated the advance of DNA Script's SYNTAX Platform, allowing scientists to print synthetic nucleic acids, avoiding the need for third-party waiting times.

Total funding - $311.3m

Last 2 fundraises

Oct 2021

$165m

SERIES C

Jan 2022

$35m

SERIES C

This company has top investors

Company values

  • Excellence: Take responsibility for your work. Aim to act, do, and behave with the goal of reaching the unreachable
  • Transparency: Give sincere, reliable, and trustworthy information. Bring objective facts, no matter how they look
  • Benevolence: Create a positive environment for everyone. Be supportive to the team, the company, and your colleagues

Founders

Thomas Ybert

(CEO & Board Director)

Previously a Metabolic Engineering Project Leader at Amyris and a Biotechnological Senior Scientist at TOTAL.

Previously an Analyst at TOTAL and an Engineer at Akuo Energy.

Previously a Research Analyst at TOTAL, a Business Analyst at URGO, and a Mining Engineer for the French Ministry of Industry. Also worked as a Portfolio Manager for a state shareholding agency.


For companies

Claim your profile to receive high quality applications from relevant candidates.

Claim profile

For job seekers

Sign in or sign up to discover relevant roles at exciting companies.

Sign in or sign up

DNA Script is hiring for 1 job on Otta!


All locations

Finance, Legal & Compliance